Showing results (71-80 of 822) with videos related to
Sort By:
Pageof 83
Journal of Crohn'S & Colitis|May 13, 2022
IL-23 Blockade in Anti-TNF Refractory IBD: From Mechanisms to Clinical RealityRaja Atreya, Markus F NeurathMethods in Molecular Biology (Clifton, N.J.)|June 2, 2016
Oxazolone-Induced Colitis as a Model of Th2 Immune Responses in the Intestinal MucosaBenno Weigmann, Markus F NeurathCytokine & Growth Factor Reviews|July 18, 2015
Interleukin-12: Functional activities and implications for diseaseSebastian Zundler, Markus F NeurathNature Reviews. Gastroenterology & Hepatology|April 1, 2026
Pathophysiology of colitis-associated colorectal cancerClemens Neufert, Markus F NeurathInflammatory Bowel Diseases|March 20, 2024
Clinical Pharmacist Counselling Improves Long-term Medication Safety and Patient-reported Outcomes in Anti-TNF-treated Patients With Inflammatory Bowel Diseases: The Prospective, Randomized AdPhaNCED TrialJohannes Plechschmidt, Konstantin Fietkau, Tobias Hepp, et al.Endoscopy International Open|August 13, 2019
Magnification endoscopy with optical chromoendoscopy shows strong correlation with histologic inflammation in patients with inflammatory bowel diseaseEntcho Klenske, Raja Atreya, Arndt Hartmann, et al.Therapeutic Advances in Gastroenterology|October 7, 2021
Case report of severe constrictive perimyocarditis and ischemic hepatitis in a Crohn's disease patient upon infliximab-induced lupus-like syndromeSimon Hirschmann, Sarah Fischer, Entcho Klenske, et al.Frontiers in Immunology|July 19, 2017
Clinical Response to Vedolizumab in Ulcerative Colitis Patients Is Associated with Changes in Integrin Expression ProfilesFriederike Fuchs, Daniela Schillinger, Raja Atreya, et al.Current Protocols in Pharmacology|February 2, 2012
Chemically induced mouse models of colitisMaximilian J Waldner, Markus F NeurathImmunotherapy|April 20, 2012
Potential avenues for immunotherapy of colitis-associated neoplasiaMaximilian J Waldner, Markus F NeurathPageof 83